Morolimumab is a human monoclonal antibody against the human Rhesus factor.[1][2]
Immune activation: Dostarlimab Other: Ibalizumab
This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.